Shree Rajivlochan Peer Comparison

BSE: 530295

₹24.20

₹0.05 (0.21%)

As on 27-Aug-2026IST

Market cap

₹10 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

215.3

P/B Ratio

1.6

Div. Yield

0 %

Edit

	Shree Rajivlochan	Ajooni Biotech	AWL Agri Business	Bikaji Foods Intl	Godrej Agrovet	Hatsun Agro	KSE	Narmada Agrobase	Prima Agro	Prism Medico
Market cap (₹ Cr)	10	67	24,356	14,643	12,468	25,817	578	103	8	41
Revenue (₹ Cr)	--	213	77,720	3,075	10,474	10,364	1,718	90	11	1
Net Profit (₹ Cr)	0.05	4.66	1,090.47	255.36	384.15	371.90	46.43	3.59	0.44	-0.40
Net Margin (%)	18.93	2.18	1.40	8.16	3.63	3.58	2.68	3.96	3.70	-40.89
RoE (%)	0.90	5.10	11.55	16.86	24.56	19.56	13.15	6.13	2.77	--
Price to Earnings	215.33	14.43	21.07	56.64	27.91	69.42	12.45	28.61	18.43	--
Price-To-Book	1.60	0.71	2.27	8.81	5.83	12.42	1.65	1.71	0.55	1.78

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Shree Rajivlochan	Godrej Agrovet	KSE	Narmada Agrobase	Ajooni Biotech
Operating Revenue	0.00	10,473.61	1,718.16	89.58	212.73
Total Income	0.24	10,582.34	1,732.44	90.80	213.79
Total Expenditure	0.17	9,639.56	1,658.60	84.97	203.49
EBITDA	-0.17	834.05	59.55	5.58	9.24
Depreciation	0.00	227.64	8.30	0.22	2.68
EBIT	-0.17	606.41	51.26	5.33	6.56
Interest	0.00	132.57	2.62	0.75	1.02
Other Income	0.24	108.73	14.29	1.23	1.06
Exceptional Items	0.00	-30.44	0.47	0.00	0.00
Profit before Tax	0.07	552.13	63.40	4.85	6.60
Provision for Tax	0.02	167.98	16.97	1.26	1.94
Profit after Tax	0.05	384.15	46.43	3.59	4.66

Liabilities (₹ Cr)

	Shree Rajivlochan	Godrej Agrovet	KSE	Narmada Agrobase	Ajooni Biotech
Shareholder's Funds	5.11	2,032.08	349.50	59.34	91.62
Minority Interest	0.00	22.10	0.00	0.00	0.00
Non-Current Liabilities	0.24	1,077.70	23.95	1.02	1.71
Current Liabilities	0.00	2,928.83	41.53	11.90	31.57
Total Liabilities	5.47	5,505.49	356.73	66.46	95.05

Assets (₹ Cr)

	Shree Rajivlochan	Godrej Agrovet	KSE	Narmada Agrobase	Ajooni Biotech
Non-Current Assets	1.33	2,894.61	62.88	11.15	32.71
Current Assets	4.03	2,758.50	349.72	60.54	74.47
Total Assets	5.47	5,505.49	356.73	66.46	95.05
Total Debt*	0.41	1,281.07	24.06	9.47	1.94
Net Current Assets	4.03	-170.33	308.19	48.64	42.90
Contingent Liabilities	--	175.24	1.40	0.05	--

Cashflow (₹ Cr)

	Shree Rajivlochan	Godrej Agrovet	KSE	Narmada Agrobase	Ajooni Biotech
Cash From Operating Activities	-0.72	969.34	142.67	-15.93	-31.97
Cash Flow from Investing Activities	--	-81.53	-118.19	-3.58	13.55
Cash from Financing Activities	-0.01	-900.84	-18.56	33.83	24.83
Net Cash Inflow / Outflow	-0.73	-13.03	5.92	14.32	6.40

Ratios

Profitability Ratios

	Shree Rajivlochan	Godrej Agrovet	KSE	Narmada Agrobase	Ajooni Biotech
ROCE (%)	-2.35	18.36	44.19	13.04	6.94
ROE (%)	0.90	24.56	13.15	6.13	5.10
ROA (%)	0.85	6.57	12.03	5.18	4.15
EBIT Margin (%)	--	5.79	2.98	9.50	3.09
Net Margin (%)	18.93	3.63	2.68	3.96	2.18
Cash Profit Margin (%)	--	0.00	0.00	0.00	0.00

Growth Ratios

	Shree Rajivlochan	Godrej Agrovet	KSE	Narmada Agrobase	Ajooni Biotech
Revenue Growth (%)	--	8.58	5.14	38.88	76.83
EBIT Growth (%)	63.75	-3.80	-62.97	140.94	181.11
Net Profit Growth (%)	146.00	3.76	-58.35	-12.13	27.00
EPS Growth (%)	146.00	3.67	-95.80	-44.00	27.00
Book Value Growth (%)	-2.61	-5.39	31.98	230.54	105.11

Valuation Ratios

	Shree Rajivlochan	Godrej Agrovet	KSE	Narmada Agrobase	Ajooni Biotech
Price / Earnings	0.00	26.41	12.54	14.31	13.71
Price / Book Value	2.13	5.83	1.65	1.71	0.71
Dividend Yield (%)	0.00	1.70	6.92	0.00	0.00
EV/EBITDA	-88.59	16.34	6.94	9.05	9.15
Market Cap (₹ Cr)	--	14,500.13	618.74	61.80	96.46

Solvency Ratios

	Shree Rajivlochan	Godrej Agrovet	KSE	Narmada Agrobase	Ajooni Biotech
Debt to Equity	0.03	0.40	0.05	0.02	0.02
Short term debt to equity ratio	--	0.33	0.00	0.15	--
Current Ratio	341.48	0.94	8.42	5.09	2.36
Quick Ratio	341.48	0.48	4.97	3.90	1.03
Interest Coverage	-95.20	5.16	25.24	7.46	7.47

Operating Efficiency Ratios

	Shree Rajivlochan	Godrej Agrovet	KSE	Narmada Agrobase	Ajooni Biotech
Debtors to sales (%)	--	6.42	0.06	39.49	7.78
Asset Turnover	0.00	1.79	4.45	1.29	1.89
Receivable days	--	20.26	0.29	89.97	46.43
Inventory Days	--	49.06	29.59	92.93	62.62
Payable days	--	33.21	2.28	3.18	9.55
Cash Conversion Cycle	--	36.11	27.59	179.71	99.49

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly